Document is current
Any future updates will be listed below
-
Authors
Bakhuis, Carsten F. J.
Gkekos, Leo
van Diest, Paul J.
van der Wall, Elsken
Fredriksson, Irma
van Dooijeweert, Carmen
Johansson, Anna L. V.
-
Funding
Funding for this research was provided by:
Strategic Program Cancer UMC Utrecht (N/A)
Strategic Program Cancer UMC Utrecht (N/A)
Stichting A Sister's Hope (N/A)
Stichting A Sister's Hope (N/A)
Stichting A Sister's Hope (N/A)
Stichting A Sister's Hope (N/A)
Private Philantropist (N/A)
Private Philantropist (N/A)
Private Philantropist (N/A)
Private Philantropist (N/A)
Swedish Cancer Society (22-2044 Pj)
Swedish Cancer Society (22-2044 Pj)
Swedish Cancer Society (22-2044 Pj)
Radiumhemmets Forskningsfonder (221153/2022)
Radiumhemmets Forskningsfonder (221153/2022)
Radiumhemmets Forskningsfonder (221153/2022)
Swedish Breast Cancer Association (F2024-0045)
Swedish Breast Cancer Association (F2024-0045)
Swedish Breast Cancer Association (F2024-0045)
Erich och Majje Näsström Donation to Karolinska Institutet (N/A)
Swedish Research Council (2021-01657)
- License Information
-
More Information
Article History
Received: 11 August 2025
Accepted: 11 February 2026
First Online: 21 February 2026
Competing interests
: PvD is a member of the advisory boards of Visiopharm, Paige, and Sectra. CvD received institutional research funding from Visiopharm, Paige, Ellogon.AI, and Gilead Sciences, and (speaker) honoraria from Benecke, Congress Care and IQVIA. CB has received institutional research funding from Gilead Sciences and (speaker) honoraria from Congress Care and Congress & Meeting Services Holland. IF has received institutional funding from MSD as part of a Master Collaboration Agreement between MSD and Karolinska Institutet. All other authors report no conflict of interest.
